Recently Discovered Diabetes Drug Reduces Weight and Lowers Blood Sugar
A recently discovered series of diabetes drugs, SGLT2 inhibitors, has been shown to the sugar levels in the blood as well as helps in reducing weight. This drug works by increasing the amount of sugar expelled in the urine. The first kind in this class of drug, Dapagliflozin, is developed jointly by AstraZeneca and Bristol-Myers Squibb and was tested in a clinical research study.
Clifford Bailey, a Clinical Science professor at Aston University, Birmingham informed WebMD that this drug differently than other drugs used for diabetes. This drug can work in conjunction with other treatment methods and can be used in any phase of the disease.
Additionally, Dapagliflozin helps diabetes patients to lose weight by causing the body to expel excess sugar. In a recent study, which was conducted for 24 weeks, patients who took Metformin and Dapagliflozintogether lost an average of 4 and 1/2 pounds more than patients who took Metformin alone.
The amount of weight lost found to be fat, not simply water weight. Those who took Dapagliflozin developed slimmer waistlines, leading the belief that this might work well as a weight loss pill. However, Bailey noted that its effectiveness got diluted when the blood sugar levels were almost normal. Hence, the potential of this drug as a weight loss drug is reducedwhen the blood sugar levels were nearly normal.
Another major benefit of Dapagliflozin is that it lowers the blood pressure and only needs to be taken once a day. Also, it does not cause the blood sugar to dip to dangerously low levels.
The drug has its side effects which include higher risk of urinary and genital infections. Also, unobserved long term consequences can occur as the drug changes the way body expels fluids.